Activist 13D/13G Filings - SILVERARC CAPITAL MANAGEMENT LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2024-02-14
8:43 pm
Purchase		13GMERSANA THERAPEUTICS INC
MRSN		SILVERARC CAPITAL MANAGEMENT LLC6,420,136
5.3%		6,420,136increase
(New Position)		View
2024-02-14
8:39 pm
Purchase		13GMOLECULAR TEMPLATES INC NE
MTEM		SILVERARC CAPITAL MANAGEMENT LLC354,608
6.6%		354,608increase
(New Position)		View
2024-02-14
8:30 pm
Purchase		13GEVOGENE LTD
EVGN		SILVERARC CAPITAL MANAGEMENT LLC3,100,000
6.1%		3,100,000increase
(New Position)		View
2023-02-07
5:38 pm
Sale		13GBENITEC BIOPHARMA INC
BNTC		SILVERARC CAPITAL MANAGEMENT LLC0
0%		-587,499decrease
(Position Closed)		View
2022-02-10
09:09 am
Unchanged		13GBENITEC BIOPHARMA INC
BNTC		SILVERARC CAPITAL MANAGEMENT LLC587,499
7.2%		0
(Unchanged)		View
2022-02-10
09:07 am
Unchanged		13GBENITEC BIOPHARMA INC
BNTC		SILVERARC CAPITAL MANAGEMENT LLC587,499
7.2%		0
(Unchanged)		View
2022-02-09
4:39 pm
Purchase		13GBENITEC BIOPHARMA INC
BNTC		SILVERARC CAPITAL MANAGEMENT LLC587,499
7.2%		587,499increase
(New Position)		View
2022-02-08
4:48 pm
Sale		13GDELCATH SYS INC
DCTH		SILVERARC CAPITAL MANAGEMENT LLC0
0%		-351,616decrease
(Position Closed)		View
2021-03-10
11:19 am
Purchase		13GDELCATH SYS INC
DCTH		SILVERARC CAPITAL MANAGEMENT LLC351,616
5.9%		351,616increase
(New Position)		View